KENNESAW LOCATION
Myopia Control in Kennesaw, GA
Is your child's prescription getting stronger every year? Myopia control treatments — Ortho-K, MiSight, and atropine — can slow progression and protect long-term eye health. Dr. Bhumi Patel at Classic Vision Care Kennesaw offers all three.
Table of Contents
1. What Is Myopia Control, and How Is It Different from Standard Glasses?
2. Why Does It Matter If Your Child's Myopia Keeps Getting Worse?
3. What Myopia Control Treatments Does Dr. Bhumi Patel Offer in Kennesaw?
4. How Do You Know Which Treatment Is Right for Your Child?
5. Does Outdoor Time Really Affect Myopia?
6. What Happens at a Myopia Control Evaluation at Classic Vision Care Kennesaw?
7. Sources
Picture a familiar scene: you are sitting in an exam chair, your child is perched on the stool across from the eye doctor, and the doctor hands you an updated prescription. The numbers are higher than last year. And the year before that. You ask whether this is normal, and you hear "yes, kids' eyes are still developing" and then the appointment is over.
If that experience resonates, you are far from alone. Myopia, or nearsightedness, is one of the most common vision conditions in the United States, affecting approximately 42% of Americans according to the American Optometric Association. For children, the concern is not just about clear vision today. It is about where the prescription ends up by the time they are adults.
The good news is that there is a clinical specialty dedicated to exactly this problem. Myopia control refers to evidence-based treatments designed to slow the rate at which a child's nearsightedness progresses. At Classic Vision Care in Kennesaw, Dr. Bhumi Patel, OD offers a full range of myopia control options to families in north Cobb County. This guide explains what those options are, what the research says about them, and what to expect when you bring your child in for a myopia control evaluation.
What Is Myopia Control, and How Is It Different from Standard Glasses?
When a child is diagnosed with myopia, the standard response is a prescription for glasses or contact lenses. Those lenses do exactly what they are supposed to do: they bend incoming light so it focuses correctly on the retina, making distant objects clear. Standard glasses are effective, time-tested, and often the right choice for visual correction.
But standard glasses are not myopia control. They correct the blur without addressing the underlying process that is making the blur worse year after year. Understanding the difference between correction and control is the first step in having a more informed conversation with your eye doctor.
What Actually Causes Myopia to Get Worse in Children?
Myopia is caused by the eye being physically too long from front to back. When light enters a myopic eye, it focuses at a point slightly in front of the retina rather than directly on it, which is why distant objects appear blurry. In a child with progressing myopia, the eye is continuing to elongate (a process called axial elongation) as the child grows.
This elongation is influenced by both genetics and environment. Children with two myopic parents have a significantly higher risk of developing myopia themselves. But genetics is not the whole story. Epidemiological research has documented a dramatic rise in myopia prevalence over recent decades, particularly in East Asian countries but also in the United States and Europe, that cannot be explained by genetics alone. The leading environmental factors are increased near work (reading, screen time, and close visual tasks) and reduced time outdoors.
How Do Myopia Control Treatments Work Differently from Regular Lenses?
Most myopia control treatments work by creating a specific pattern of light focus across the entire retina, not just the central region. With a standard single-vision lens, the center of the visual field is corrected, but the peripheral retina receives a pattern called hyperopic defocus. This means light from the periphery focuses behind the retina rather than on it. Some research suggests this peripheral hyperopic defocus signals the eye to continue growing to catch up, potentially contributing to continued progression.
Myopia control lenses are designed to deliver myopic defocus in the peripheral retina. Peripheral light focuses in front of the retina rather than behind it, and this appears to signal the eye to slow its elongation. Atropine eye drops work through a different pathway, likely involving retinal signaling systems that regulate eye growth, rather than optics.
To learn more about how myopia control works and why it has become a growing area of clinical focus, our overview page offers a broader introduction.
Why Does It Matter If Your Child's Myopia Keeps Getting Worse?
Many parents accept that their child will simply wear glasses the way they did. The assumption is that myopia is an inconvenience, a quality-of-life issue that glasses or contacts manage just fine. This framing is understandable, but it misses an important part of the picture.
The concern with progressing myopia is not just about the prescription number. It is about what a higher prescription means for long-term eye health.
What Are the Long-Term Health Risks of High Myopia?
A landmark study published in the journal Ophthalmology by Holden and colleagues modeled the global implications of the myopia epidemic and quantified the association between myopia severity and serious ocular complications. The findings are significant:
- •High myopia (a prescription at or above -6.00 D) is associated with a 21-fold increased risk of retinal detachment compared to eyes with no myopia.
- •The risk of myopic maculopathy, a form of central vision damage, is approximately 9 times higher in eyes with high myopia.
- •The risk of glaucoma is approximately 3 times higher.
These are not rare events. They are conditions that can significantly impair or eliminate functional vision, and they are directly linked to how many diopters of myopia a person accumulates over their lifetime.
Here is why this matters for treatment decisions: as a hypothetical illustration, if a 9-year-old is currently at -2.00 D and progressing at a typical rate, they might reach -7.00 D or higher by age 18 without any intervention. A treatment that slows progression by 50 to 60 percent might leave that same child at -3.50 D or -4.00 D at adulthood. The difference between -4.00 D and -7.00 D is not just fewer diopters. It represents a fundamentally different lifetime risk profile for retinal disease, glaucoma, and vision loss.
Myopia control does not reverse existing myopia or eliminate the need for correction. But it can meaningfully change where a child ends up on the severity spectrum, and that has real implications for their eye health for the rest of their life.
What Myopia Control Treatments Does Dr. Bhumi Patel Offer in Kennesaw?
At Classic Vision Care's Kennesaw office at 1615 Ridenour Blvd Suite 201, Dr. Bhumi Patel, OD specializes in myopia management for children and adolescents. Families in north Cobb County, including those near Kennesaw Mountain and throughout the Ridenour Blvd corridor, have access to the full spectrum of clinically validated myopia control treatments without traveling to Atlanta.
Dr. Patel currently offers four evidence-based treatment approaches:
Is Orthokeratology (Ortho-K) Right for Your Child?
Orthokeratology, commonly known as ortho-k, uses specially designed rigid gas-permeable contact lenses worn overnight while the child sleeps. The lenses temporarily reshape the surface of the cornea so that the child can see clearly during the day without wearing glasses or contacts. By morning, the lenses are removed, and the child typically has clear, corrected vision throughout the day.
Beyond the convenience of lens-free daytime vision, ortho-k has a meaningful myopia control effect. A clinical study by Cho and colleagues, published in Optometry and Vision Science, followed children wearing ortho-k lenses versus standard spectacles over two years and found that ortho-k wearers showed approximately 46% less axial elongation. The eye grew significantly less in the ortho-k group compared to the control group.
Ortho-k is often a particularly good fit for active children: athletes, swimmers, and those involved in sports where glasses are inconvenient. Because the lenses are worn at night, there is no lens handling required during daytime activities.
To learn more about how ortho-k lenses work and what to expect, visit our dedicated ortho-k lenses for myopia control page.
What Are MiSight Contact Lenses, and How Do They Work?
MiSight 1 day lenses, manufactured by CooperVision, are soft daily disposable contact lenses worn during waking hours. They look and feel similar to standard daily soft contacts but have a proprietary dual-focus optical design: the center of the lens corrects the child's distance vision, while surrounding treatment zones create myopic defocus in the peripheral retina.
MiSight holds a distinction that sets it apart from other options: it is the first and only contact lens to receive FDA clearance specifically for slowing the progression of myopia in children aged 8 to 12 at the initiation of treatment. That clearance was based on a three-year randomized controlled trial by Chamberlain and colleagues, published in the journal Optometry and Vision Science. The trial compared MiSight to single-vision daily disposable lenses in 144 children and found that the MiSight group experienced 59% less myopia progression and 52% less axial elongation over three years.
For children who are comfortable wearing soft contact lenses and whose parents want a treatment with the strongest available regulatory backing, MiSight is often the primary recommendation.
More details about MiSight lenses for myopia control are available on our dedicated overview page.
Can Atropine Eye Drops Slow Myopia Progression?
Low-dose atropine eye drops are a once-nightly treatment in which a single drop of diluted atropine solution is placed in each eye before the child goes to sleep. Atropine has been used in eye care for over a century in higher concentrations for various purposes, but the low-dose formulation used for myopia control (most commonly 0.01% concentration) has a different and more favorable profile.
The ATOM2 clinical trial, published in Ophthalmology by Chia and colleagues, compared three concentrations of atropine (0.5%, 0.1%, and 0.01%) in 400 children over two years. The 0.01% concentration slowed myopia progression by approximately 60% while producing minimal side effects: nearly no clinically significant near blur and only slight pupil enlargement that most children do not notice in daily life. When atropine was stopped after two years, the 0.01% group showed minimal rebound. Progression did not spike when the treatment was discontinued, unlike what was observed with higher concentrations.
Atropine drops are often a practical option for younger children who are not yet ready to handle contact lenses, or as a combination therapy alongside ortho-k in children with more aggressive progression patterns.
Visit our myopia control atropine eye drops page for more information on how this treatment works and what parents can expect.
Do Multifocal Lenses Help with Myopia Control?
Multifocal contact lenses are soft lenses worn during the day that use a multi-zone optical design to create peripheral myopic defocus. Unlike MiSight, these lenses are used off-label for myopia control purposes and are not FDA-cleared specifically for this indication. However, they do have clinical evidence supporting their efficacy.
The BLINK Study, a multi-center randomized clinical trial funded by the National Eye Institute and published in JAMA, compared high-add multifocal soft lenses to single-vision lenses in 294 children. High-add multifocal lenses reduced myopia progression by approximately 43% compared to single-vision lenses over the study period.
Multifocal soft lenses may be a suitable alternative for children who prefer the feel of soft daily-wear lenses but are not candidates for MiSight specifically. Dr. Bhumi Patel can discuss whether this option fits your child's profile at a myopia control evaluation.
Our myopia control multifocal lenses page covers this treatment in more detail.
How Do You Know Which Treatment Is Right for Your Child?
With four clinically validated treatment options available, a natural question is: which one is best? The honest answer is that "best" depends heavily on the individual child. There is no head-to-head randomized trial that has compared all four treatments against each other directly, and the decision involves factors that vary from child to child and family to family.
What Factors Does Dr. Bhumi Patel Consider When Recommending a Treatment?
At the myopia control evaluation, Dr. Patel will take into account several factors before making a recommendation:
Age and developmental readiness. Younger children (roughly 6 to 8 years old) may not yet be ready for contact lens handling. Atropine drops or multifocal spectacle lenses may be more appropriate for the youngest patients. MiSight is FDA-cleared for children 8 and older. Ortho-k and atropine can both be started earlier in the right circumstances.
Current prescription and rate of progression. A child who has gained one diopter per year for three consecutive years is in a different clinical situation than a child who has been stable with only mild progression. Axial length measurement, taken with a device called a biometer, gives a precise measurement of how long the eye actually is. This is a better predictor of future risk than the prescription number alone.
Contact lens readiness. Both MiSight and ortho-k require the child to handle contact lenses (or for a parent to assist with ortho-k placement). If a child is anxious about contact lenses or if the family prefers a simpler routine, atropine drops have a straightforward once-nightly administration that does not require lens handling.
Lifestyle and activity level. Children who are serious athletes, swimmers, or involved in activities where glasses and contacts are inconvenient often do very well with ortho-k, because it provides glasses-free daytime vision. Children with a very consistent daily routine and a preference for soft lens feel often adapt well to MiSight.
Compliance. A treatment that is used consistently will outperform a theoretically better treatment that the child resists or skips. Part of the recommendation process is a realistic conversation about which option the family can sustain over the years it takes to achieve meaningful slowing of progression.
The pediatric eye exams page on our site explains what a comprehensive pediatric eye evaluation at Classic Vision Care includes, and the eye doctor Kennesaw GA hub page has broader information about our Kennesaw location and team.
Does Outdoor Time Really Affect Myopia?
Yes, and in ways that may surprise you. Many parents assume that the connection between screen use and myopia is about near work, that staring at screens too long causes the eye to become stuck in a near-focus state. While near work is a risk factor, the outdoor time connection appears to be driven by something different: light intensity.
Natural outdoor light on a typical day is dramatically brighter than any indoor environment. A cloudy outdoor day might measure 10,000 lux; a well-lit classroom typically measures 300 to 500 lux. Sunlight on a bright day can exceed 100,000 lux. This difference in light intensity appears to matter biologically. Research suggests that bright light stimulates dopamine release in the retina, and retinal dopamine is thought to play a role in regulating axial elongation.
A randomized trial by Wu and colleagues, published in Ophthalmology, added 40 minutes of outdoor recess per day at school for a group of first-grade children in Taiwan and compared their myopia development over one year to a control group that did not receive additional outdoor time. The result: new myopia cases were 54% lower in the outdoor intervention group by the end of the year.
The current clinical recommendation from myopia research organizations is at least 90 minutes of outdoor time per day for children, particularly those who are already myopic or at elevated risk. This does not need to be vigorous exercise. Walking, playing, or simply being outside in bright light is the key factor.
Two important caveats apply here. First, outdoor time is protective but not a substitute for clinical myopia control treatment in a child whose prescription is already progressing. Second, adequate sun protection (UV-blocking sunglasses and sunscreen) is still important, and outdoor time should be balanced with common-sense sun safety practices.
What Happens at a Myopia Control Evaluation at Classic Vision Care Kennesaw?
If you are considering myopia control for your child, the first step is scheduling a dedicated myopia management evaluation at our Kennesaw office. Here is what to expect.
Before the appointment: Gather any previous glasses or contact lens prescriptions, particularly from the past two to three years. The rate of change over time is one of the most important clinical data points. If your child has had eye exams elsewhere, a summary or records from those visits is helpful but not required.
During the evaluation: Dr. Bhumi Patel will perform a comprehensive eye examination that includes a full refraction (measuring the current prescription), assessment of eye health, and biometry. Biometry is an instrument measurement of the physical length of the eye. It is quick and painless: your child simply looks into a device for a few seconds while the measurement is taken. Axial length is a critical metric in myopia management because it tracks the actual elongation of the eye, not just the prescription, and allows the doctor to estimate future progression risk more precisely.
Dr. Patel will review your child's myopia history, discuss which treatment options are appropriate given the examination findings, explain the evidence behind each option in terms you can understand, and make a personalized recommendation. There is no pressure to decide at the first appointment. The goal is to make sure you have the information you need.
After the first appointment: Myopia control is an ongoing process. Follow-up visits are typically scheduled every six months to measure axial length, compare to baseline, and assess how well the treatment is working. Adjustments to the treatment plan can be made over time based on the response.
To read about what a broader pediatric eye exam involves, visit that page for more information on what to expect when bringing your child in for a children's vision evaluation.
Classic Vision Care Kennesaw
1615 Ridenour Blvd, Suite 201
Kennesaw, GA 30152
Phone: (770) 499-2020
Hours: Monday through Thursday, 9:00 am to 6:00 pm; Friday, 9:00 am to 5:00 pm; Saturday, 9:00 am to 2:00 pm; Sunday: Closed
Classic Vision Care also has a Marietta location at 3535 Roswell Rd, Suite 8, Marietta, GA for families in that area.
Ready to take the next step?
Schedule a myopia control evaluation for your child at Classic Vision Care Kennesaw. Dr. Bhumi Patel and our team are here to help you understand your child's options and build a treatment plan that fits their life. Call us at (770) 499-2020 or book an appointment online.
This article is for informational purposes only and does not constitute medical advice. Please consult with an eye care professional for diagnosis and treatment.
Related Services at Kennesaw
Also Available at Our Marietta Location
We offer the same services at our Marietta office.
View Marietta Page →This information is for educational purposes only and does not replace a professional eye examination. Please consult your optometrist for personalized medical advice.
Ready to Get Started?
Book your appointment at our Kennesaw clinic today.